Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 91.77
0.00 (0.00%)
At close: Apr 3, 2025
Citi Pharma Ratios and Metrics
Market cap in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 2, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2018 - 2019 |
| Market Capitalization | 20,966 | 6,511 | 4,875 | 7,457 | - | - | Upgrade
|
| Market Cap Growth | 186.90% | 33.55% | -34.62% | - | - | - | Upgrade
|
| Enterprise Value | 21,584 | 6,236 | 4,443 | 5,627 | - | - | Upgrade
|
| Last Close Price | 91.77 | 26.42 | 17.82 | 27.26 | - | - | Upgrade
|
| PE Ratio | 25.50 | 7.81 | 7.41 | 11.41 | - | - | Upgrade
|
| PS Ratio | 1.59 | 0.53 | 0.39 | 0.76 | - | - | Upgrade
|
| PB Ratio | 3.92 | 1.16 | 0.91 | 1.58 | - | - | Upgrade
|
| P/TBV Ratio | 2.91 | 1.16 | 0.91 | 1.58 | - | - | Upgrade
|
| P/FCF Ratio | 223.45 | 8.46 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 29.95 | 4.87 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.64 | 0.50 | 0.36 | 0.57 | - | - | Upgrade
|
| EV/EBITDA Ratio | 15.06 | 4.65 | 3.53 | 5.28 | - | - | Upgrade
|
| EV/EBIT Ratio | 16.83 | 5.17 | 3.81 | 5.66 | - | - | Upgrade
|
| EV/FCF Ratio | 230.04 | 8.11 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.26 | 0.34 | 0.20 | 0.07 | 0.49 | Upgrade
|
| Debt / EBITDA Ratio | 1.25 | 1.08 | 1.46 | 0.88 | 0.50 | 1.57 | Upgrade
|
| Debt / FCF Ratio | 19.17 | 1.89 | - | - | - | - | Upgrade
|
| Asset Turnover | - | 1.16 | 1.37 | 1.34 | 1.29 | 1.86 | Upgrade
|
| Inventory Turnover | - | 3.72 | 5.06 | 6.82 | 6.02 | 6.24 | Upgrade
|
| Quick Ratio | 0.59 | 0.68 | 0.80 | 1.15 | 1.92 | 0.31 | Upgrade
|
| Current Ratio | 1.24 | 1.36 | 1.48 | 1.86 | 2.45 | 1.11 | Upgrade
|
| Return on Equity (ROE) | - | 15.14% | 13.05% | 14.40% | 13.16% | 15.79% | Upgrade
|
| Return on Assets (ROA) | - | 7.05% | 8.06% | 8.49% | 7.96% | 8.38% | Upgrade
|
| Return on Capital (ROIC) | - | 10.54% | 11.34% | 12.01% | 11.62% | 12.00% | Upgrade
|
| Return on Capital Employed (ROCE) | 23.00% | 20.60% | 21.10% | 19.40% | 12.20% | 20.80% | Upgrade
|
| Earnings Yield | 3.92% | 12.80% | 13.50% | 8.77% | - | - | Upgrade
|
| FCF Yield | 0.45% | 11.82% | -26.33% | -12.38% | - | - | Upgrade
|
| Dividend Yield | 3.73% | 12.30% | 14.03% | - | - | - | Upgrade
|
| Payout Ratio | 90.37% | 68.53% | - | 47.66% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.01% | - | -0.70% | -21.65% | -88.38% | - | Upgrade
|
| Total Shareholder Return | 3.72% | 12.30% | 13.32% | -21.65% | -88.38% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.